Risk of second primary cancer following differentiated thyroid cancer
- 28 January 2004
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 31 (5) , 685-691
- https://doi.org/10.1007/s00259-003-1448-y
Abstract
Concerns remain over the risk of cancer following differentiated thyroid carcinoma and its causes. Iodine-131 (131I) and external irradiation are known to have potential carcinogenic effects. Thyroid carcinoma is a polygenic disease which may be associated with other malignancies. We investigated the incidence of second cancer and its aetiology in a cohort of 875 patients (146 men, 729 women) with differentiated thyroid carcinoma originating from Basse-Normandie, France. Cancer incidence was compared with that of the general population of the Département du Calvados matched for age, gender and period. The cumulative proportion of second cancer was estimated using the life-table method. Factors that correlated with the risk of second cancer were studied using the Cox model. After a median follow-up of 8 years, 58 second cancers had been observed. Compared with general population incidence rates, there was an overall increased risk of second cancer in women [standardised incidence ratio (SIR)=1.52; P0.20). Increased risk related to cancers of the genitourinary tract (SIR=3.31; P PPP131I was related to the risk. These data confirm that women with differentiated thyroid carcinoma are at risk of developing a second cancer of the genitourinary tract and kidney. Only age and medical history of primary cancer before thyroid carcinoma are risk factors for second cancer. Common environmental or genetic factors as well as long-term carcinogenic effects of primary cancer therapy should be considered.Keywords
This publication has 18 references indexed in Scilit:
- Second primary malignancies in thyroid cancer patientsBritish Journal of Cancer, 2003
- Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based StudyJournal of Clinical Endocrinology & Metabolism, 2001
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2001
- Familial adenomatous polyposisSeminars in Surgical Oncology, 2000
- Familial papillary thyroid microcarcinoma: a new clinical entityThe Lancet, 1999
- Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1998
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Leukaemias and cancers following iodine-131 administration for thyroid cancerBritish Journal of Cancer, 1997
- Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.1995
- Second Primary Tumors Following Thyroid Cancer a Swedish Record-Linkage StudyActa Oncologica, 1990